This webinar is designed to address the challenges related to anti-VEGF access in retina practices. Hosted by retina specialists and retinal practice CEOs, the program will tackle both clinical and business-related issues including step therapy, MACRA/MIPS, payor-related obstacles, and more. A previously recorded live question-and-answer session will answer many of your questions and concerns.
This certified CME activity is designed for retina specialists, ophthalmologists, pharmacists and other professionals involved in the treatment and management of patients with retinal disorders.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
• Implement the most up-to-date decision-making tools to determine optimal treatment for each patient and improve communication with patients about their treatment options.
• Advocate against prior authorizations and step policies and learn how to appeal them.
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As an independent chartered chapter of the American College of Healthcare Executives, ACHE – SouthEast Texas Chapter is authorized to award 1.0 hours of ACHE Qualified Education credit toward advancement or recertification in the American College of Healthcare Executives.
Participants in this program who wish to have it considered for ACHE Qualified Education credit should list their attendance when they apply to the American College of Healthcare Executives for advancement or recertification.
Please be sure to self-report your credits using link titled “My education Credit” on your myACHE profile page. If additional assistance is needed members should be directed to ACHE Customer Service (email@example.com or 312-424-9400).
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN 0062-9999-20-126-H01-P, 1-hour home study credit (0.1 CEU)
Release date: May 12, 2020 Expiration date: May 12, 2021
This application-based activity is accredited for 1 home study contact hour (0.1 CEU) for pharmacists. To claim credit, participants must sign-in/register and participate in the entire activity. No partial credit will be issued.
Nathan Steinle, MD (Moderator)
California Retina Consultants
Santa Barbara, CA
Collaborative Associate Professor
Department of Ophthalmology
University of South Florida Morsani
College of Medicine
Director of Research, Retina Vitreous
Associates of Florida
Sean Goodale, CPA, MBA
Chief Executive Officer
Kansas City, MO
Alison L. Ratliff, MBA
Chief Executive Officer
South Coast Retina Center
Santa Barbara, CA
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Nathan Steinle, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Genentech, Novartis and Regeneron Pharmaceuticals; Grant Research Support: Genentech, Novartis and Regeneron Pharmaceuticals; Speaker: Genentech, Novartis and Regeneron Pharmaceuticals
David Eichenbaum, MD, FAAO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alimera Sciences, Allergan, DORC, Eyepoint Pharmaceuticals, Genentech, Gyroscope, Kodiak, Novartis, Recens Medical, and Regeneron Pharmaceuticals; Grant/Research Support: Alimera, Allergan, Chengdu, Clearside Biomedical, Genentech, Gyroscope, Kodiak, Mylan, NGM, Novartis, Opthea, and Ophthotech; Speaker: Allergan, Genentech, and Novartis; Stock/Shareholder: Boston Image Reading Center, Clearside Biomedical, Hemera Biosciences, and Network Eye.
Sean Goodale,CPA, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Speaker: Genentech, Regeneron Pharmaceuticals.
Alison L. Ratliff, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Novartis, and REGENXBIO Inc; Speaker: Genentech, Regeneron Pharmaceuticals.
EDITORIAL SUPPORT DISCLOSURES
The staff and planners involved in this activity have no financial relationships with commercial interests.
Caitlin Mardis, PharmD, University of South Carolina College of Pharmacy staff has nothing to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The University of South Carolina College of Pharmacy, or Regeneron Pharmaceuticals.